Elikem Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Kalol, Gujarat, India, established in 1992.
1992 Kalol, Gujarat, India Active
Last Updated:
Access Report
About Elikem Pharmaceuticals Private Limited

Elikem Pharmaceuticals Private Limited, a active private limited company, was established on 17 August 1992 in Kalol, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1992PTC018162. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.25 M and a paid-up capital of ₹1.25 M.

It upholds a compliant status. Its leadership includes Prakashkumar Shivramdas Patel (Director), Vasantbhai Ambalal Raval (Director), Chirag Girishbhai Patel (Director). Past directors included Vinodkumar Ambalal Patel, Ajitkumar Ramanlal Patel, Ghanshyambhai Jayantilal Patel. It holds ₹3.86 Cr open charges and ₹1.35 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Elikem Pharmaceuticals Pvt. Ltd. Plot No : 816/1, At : Rakanpur, Tal : Ka, Lol,, Kalol, Gujarat, 382721.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231GJ1992PTC018162

  • Registration Number

    018162

  • Incorporation Date

    17 August 1992

  • Authorized Capital

    ₹1.25 M

  • Paid-Up Capital

    ₹1.25 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.25 M
  • Paid Up Capital ₹ 1.25 M
  • Company Age 33 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 3.86 Cr
  • Satisfied Charges ₹ 1.35 Cr
  • Revenue Growth **** 23.04%
  • Profit Growth **** 47.99%
  • Ebitda **** 47.53%
  • Net Worth 29.82%
  • Total Assets **** 5.23%
Company report

Elikem Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Elikem Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Elikem Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Prakashkumar Shivramdas Patel Director 01 Apr 2010 Current
Vasantbhai Ambalal Raval Director 16 Jun 2014 Current
Chirag Girishbhai Patel Director 01 Apr 2005 Current
Pratik Girishbhai Patel Director 01 Apr 2005 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2016 Past
Pramod Abcsdd Director 16 Jun 2014 Past
Pramod Abcsdd Director 16 Jun 2014 Past
Pramod Abcsdd Director 07 Nov 2015 Past
Pramod Abcsdd Additional Director 16 Jun 2014 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elikem Pharmaceuticals.

Elikem Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 23.04% increase. The company also saw a substantial improvement in profitability, with a 47.99% increase in profit. The company's net worth Soared by an impressive increase of 29.82%.

Elikem Pharmaceuticals revenue growth over time
Elikem Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 23.04%
*******
*******
*******
*******
Revenue from Operations
*******
 23.00%
*******
*******
*******
*******
Total Assets
*******
 5.23%
*******
*******
*******
*******
Profit or Loss
*******
 47.99%
*******
*******
*******
*******
Net Worth
*******
 29.82%
*******
*******
*******
*******
EBITDA
*******
 47.53%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elikem Pharmaceuticals?

In 2024, Elikem Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹38,600,000.00

Satisfied Charges

₹13,521,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 3.16 Cr
  • Sidbi : 0.70 Cr
Latest Charge Details
Date Lender Amount Status
29 Jul 2023 Hdfc Bank Limited ₹2.50 M Open
26 Sep 2022 Hdfc Bank Limited ₹0.90 M Open
09 Aug 2021 Sidbi ₹7.00 M Open
30 Nov 2020 Hdfc Bank Limited ₹2.82 Cr Open
02 Jun 2020 Sidbi ₹5.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Elikem Pharmaceuticals?

Unlock and access historical data on people associated with Elikem Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Elikem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elikem Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elikem Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Elikem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Elikem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 28.20 M registered on 30 Nov 2020 with Charge ID 100392251 was modified on 22 Nov 2023. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 2.50 M with Charge ID 100756296 was registered on 29 Jul 2023. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.90 M with Charge ID 100615177 was registered on 26 Sep 2022. was completed.

  • Charges

    The activity A charge registered on 02 Jun 2020 via Charge ID 100338073 with Sidbi was fully satisfied on 24 Dec 2021. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Elikem Pharmaceuticals Private Limited?

The CIN of Elikem Pharmaceuticals Private Limited is U24231GJ1992PTC018162.

Where is Elikem Pharmaceuticals Private Limited headquartered?

Elikem Pharmaceuticals Private Limited is headquartered at Elikem Pharmaceuticals Pvt. Ltd. Plot No : 816/1, At : Rakanpur, Tal : Ka, Lol,, Kalol, Gujarat, 382721.

When was Elikem Pharmaceuticals Private Limited incorporated?

Elikem Pharmaceuticals Private Limited was incorporated on 17 August 1992.

Who are the current directors of Elikem Pharmaceuticals Private Limited?

The current directors of Elikem Pharmaceuticals Private Limited are

What is the primary industry of Elikem Pharmaceuticals Private Limited?

The primary industry of Elikem Pharmaceuticals Private Limited is Manufacturing.

Is Elikem Pharmaceuticals Private Limited a listed company?

Elikem Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Elikem Pharmaceuticals Private Limited?

The authorized capital of Elikem Pharmaceuticals Private Limited is ₹1.25 M, and the paid-up capital is ₹1.25 M.

What is the compliance status of Elikem Pharmaceuticals Private Limited?

The compliance status of Elikem Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available